Granules CPLP

completed

Granules India Limited (“Granules”) is a leading Contract Manufacturing Organization (“CMO”) supplying high volume Active Pharmaceutical Ingredients (“APIs”) and Pharmaceutical Formulation Intermediates (“PFIs”) to the bulk over-the-counter (“OTC”) drugs industry in the U.S., Europe, Latin America, Australia and India. Paracetamol (used in Tylenol and Panadol brand names in the U.S. and Europe, respectively) and ibuprofen (Advil and Motrin) are the company’s main products, but it also supplies the industry with guaifenesin (ultimately used in cough medications) and metformin (anti-diabetes drug ingredient).The company has four production units in three locations in the vicinity of Hyderabad, in south India. Granules management and IFC’s industry specialist have identified a number of energy and water efficiency projects, including solvent recovery as well as cleaner production improvements at the company’s Jeedimetla API facility, which will have beneficial environmental impacts (together, the “Cleaner Production project”). For example, the company will recover more of the steam and condensate used in production and recycle them, thereby reducing its energy and water intake. Variable Frequency Drives (“VFDs”) and appropriate scaling of certain motors and cooling towers will further contribute to the company’s energy efficiency and bottom line.